Company at a Glance
Price
Infographic
Overview
Merck is a global pharmaceutical and chemical company founded in 1668 in Darmstadt, Germany. It was originally a supplier of traditional chemicals, but later expanded into pharmaceuticals, life sciences, and performance materials. Merck is also known as Merck KGaA, as it is a family-owned company with around 50% of its shares controlled by the descendants of its founder, Friedrich Jacob Merck.
The company has a strong presence in Europe and the United States, as well as in emerging markets such as China, India, and Latin America. It employs over 57,000 people and generates annual revenues of around 14 billion euros.
Merck's pharmaceutical division focuses on developing and commercializing innovative medicines in various therapeutic areas, including oncology, neurology, immunology, and cardiovascular diseases. Its life sciences division provides products and services for research, development, and production in the biopharmaceutical and biotechnological industries. The performance materials division provides materials and technologies for various industries, including healthcare, electronics, coatings, and cosmetics.
The company's mission is to "empower scientists and engineers to create and make life-changing innovations that improve people's lives." It is committed to sustainability and has set ambitious targets to reduce its environmental impact, promote diversity and inclusion, and improve access to healthcare for underserved populations.
Merck is also actively involved in corporate social responsibility initiatives, including providing disaster relief and supporting education and community development programs around the world.
What is special about the company?
π Want to read more about Merck?
Sign up for free
or
log in
π Claim your free eBook: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
TWVyY2sgaX MgYSBnbG9i YWwgcGhhcm 1hY2V1dGlj YWwgYW5kIG hlYWx0aGNh cmUgY29tcG FueSB0aGF0 IGhhcyBiZW VuIGluIG9w ZXJhdGlvbi Bmb3Igb3Zl ciAzNTAgeW VhcnMsIG1h a2luZyBpdC BvbmUgb2Yg dGhlIG9sZG VzdCBhbmQg bGFyZ2VzdC BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMgaW4gdG hlIHdvcmxk LiBJdCBoYX MgYSBsb25n IGhpc3Rvcn kgb2YgaW5u b3ZhdGlvbi BhbmQgcmVz ZWFyY2gsIG xlYWRpbmcg dG8gdGhlIG RldmVsb3Bt ZW50IG9mIG 51bWVyb3Vz IG1lZGljYX Rpb25zIGFu ZCB2YWNjaW 5lcyB0aGF0 IGhhdmUgc2 lnbmlmaWNh bnRseSBpbX Byb3ZlZCBn bG9iYWwgaG VhbHRoLiBU aGUgY29tcG FueSBhbHNv IGhhcyBhIH N0cm9uZyBj b21taXRtZW 50IHRvIHN1 c3RhaW5hYm lsaXR5IGFu ZCBjb3Jwb3 JhdGUgcmVz cG9uc2liaW xpdHksIGVt cGhhc2l6aW 5nIGV0aGlj YWwgYnVzaW 5lc3MgcHJh Y3RpY2VzIG FuZCBnaXZp bmcgYmFjay B0byB0aGUg Y29tbXVuaX RpZXMgaW4g d2hpY2ggaX Qgb3BlcmF0 ZXMuIE1lcm NrIGlzIGFs c28ga25vd2 4gZm9yIGl0 cyBkaXZlcn NlIHdvcmtm b3JjZSBhbm QgaW5jbHVz aXZlIGN1bH R1cmUsIHdp dGggYSBmb2 N1cyBvbiBw cm9tb3Rpbm cgZGl2ZXJz aXR5IGFuZC BpbmNsdXNp b24gaW4gYW xsIGFzcGVj dHMgb2YgaX RzIG9wZXJh dGlvbnMuIE FkZGl0aW9u YWxseSwgTW VyY2sgaGFz IGEgc3Ryb2 5nIGZvY3Vz IG9uIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBh bmQgaW52ZX N0cyBoZWF2 aWx5IGluIG 5ldyB0ZWNo bm9sb2dpZX MgYW5kIGlu bm92YXRpb2 5zIHRvIGNv bnRpbnVlIG RyaXZpbmcg c2NpZW50aW ZpYyBhZHZh bmNlbWVudH MgaW4gdGhl IGhlYWx0aG NhcmUgaW5k dXN0cnkuIE 92ZXJhbGws IE1lcmNrJ3 MgZGVkaWNh dGlvbiB0by BpbXByb3Zp bmcgZ2xvYm FsIGhlYWx0 aCwgY29tbW l0bWVudCB0 byBldGhpY2 FsIGFuZCBy ZXNwb25zaW JsZSBidXNp bmVzcyBwcm FjdGljZXMs IGFuZCBlbX BoYXNpcyBv biBkaXZlcn NpdHkgYW5k IHJlc2Vhcm NoIG1ha2Ug aXQgYSB1bm lxdWUgYW5k IHJlc3BlY3 RlZCBjb21w YW55IGluIH RoZSBwaGFy bWFjZXV0aW NhbCBpbmR1 c3RyeS4=
What the company's business model?
π Want to read more about Merck?
Sign up for free
or
log in
π Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!
VGhlIE1lcm NrIGNvbXBh bnkgaXMgYS BnbG9iYWwg cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B0aGF0IG9w ZXJhdGVzIH VuZGVyIGEg dHJhZGl0aW 9uYWwgYnVz aW5lc3MgbW 9kZWwuIFRo aXMgbWVhbn MgdGhhdCBp dCBjcmVhdG VzLCBtYW51 ZmFjdHVyZX MsIGFuZCBt YXJrZXRzIH ByZXNjcmlw dGlvbiBkcn VncywgdmFj Y2luZXMsIG Jpb2xvZ2lj IHRoZXJhcG llcywgYW5p bWFsIGhlYW x0aCBwcm9k dWN0cywgYW 5kIG92ZXIt dGhlLWNvdW 50ZXIgbWVk aWNhdGlvbn MuIFRoZSBj b21wYW55J3 MgbWFpbiBy ZXZlbnVlIH NvdXJjZSBp cyB0aHJvdW doIHRoZSBz YWxlIG9mIH RoZXNlIHBy b2R1Y3RzIH RvIGhlYWx0 aCBjYXJlIH Byb2Zlc3Np b25hbHMgYW 5kIGRpcmVj dGx5IHRvIG NvbnN1bWVy cy4gTWVyY2 sgYWxzbyBl bmdhZ2VzIG luIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCBvZi BuZXcgbWVk aWNpbmVzLC BhbmQgaGFz IGEgbGFyZ2 UgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz IGZvY3VzZW Qgb24gdGhl cmFwZXV0aW MgYXJlYXMg c3VjaCBhcy BvbmNvbG9n eSwgY2FyZG lvdmFzY3Vs YXIgZGlzZW FzZXMsIHZh Y2NpbmVzLC BpbmZlY3Rp b3VzIGRpc2 Vhc2VzLCBh bmQgYW5pbW FsIGhlYWx0 aC4gSW4gYW RkaXRpb24g dG8gZGV2ZW xvcGluZyBh bmQgc2VsbG luZyBpdHMg b3duIHByb2 R1Y3RzLCBN ZXJjayBhbH NvIGVuZ2Fn ZXMgaW4gcG FydG5lcnNo aXBzIGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIG90 aGVyIGNvbX BhbmllcyBp biB0aGUgaG VhbHRoY2Fy ZSBpbmR1c3 RyeS4=
Sensitivity to interest rates
The sensitivity of Merck & Co.βs earnings, cash flow, and valuation to changes in interest rates can be analyzed through several factors:
1. Earnings Sensitivity: Merckβs earnings are indirectly sensitive to interest rates. Higher interest rates can lead to increased borrowing costs if the company needs to finance operations, research and development, or acquisitions. Additionally, higher rates may constrain consumer spending, potentially impacting sales of pharmaceuticals. Conversely, lower interest rates may facilitate capital investment and expansion.
2. Cash Flow Sensitivity: Merckβs cash flow can be affected by interest rates primarily through its debt obligations. If interest rates rise, the cost of servicing any variable-rate debt will increase, potentially reducing free cash flow. Lower rates can positively impact cash flow by lowering interest expenses. Moreover, changes in interest rates can influence the timing and amount of cash flows received from customers, especially in a tight economic environment.
3. Valuation Sensitivity: The valuation of Merck, like other companies, is sensitive to changes in interest rates due to the discounted cash flow (DCF) methodology generally used to estimate a companyβs value. When interest rates rise, the discount rate used in DCF calculations increases, which can lead to a lower present value of future cash flows, thus reducing the companyβs valuation. Conversely, lower interest rates can enhance valuation by lowering the discount rate and increasing the present value of future cash flows.
In summary, while Merckβs operations can be influenced by changes in interest rates, the sensitivity may not be as pronounced as in highly leveraged companies. The impact on earnings, cash flow, and valuation will depend on the companyβs debt levels, capital structure, and market dynamics.
Interesting facts about the company
π Want to read more about Merck?
Sign up for free
or
log in
π₯ Get our free eBook now: "The Checklist Value Investor β A Smarter Way to Pick Stocks"
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvNX owZmx5ZTJB cEZ0SVRRMD FCZFkud2Vi cCIgYWx0PS JNZXJjayIg dGl0bGU9Ik 1lcmNrIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTkwIHdp ZHRoPTkwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE 1lcmNrPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +ZjCBKb2lu IG5vdyB0by BnZXQgPGk+ IlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3MiPC9pPi BhdCBubyBj b3N0CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IAogICAgIC AgIAogICAg ICAgIDxzcG FuIGNsYXNz PSdibHVycm VkLXRleHQn PgogICAgIC AgICAgICBU V1Z5WTJzZ0 ptIEZ0Y0Rz Z1EyOHUgTE NCcmJtOTNi aSBCaGN5Qk 5VMFFnIGIz VjBjMmxrWl MgQjBhR1Vn Vlc1cCBkR1 ZrSUZOMFlY IFJsY3lCaG JtUWcgUTJG dVlXUmhMQy BCcGN5QnZi bVVnIGIyWW dkR2hsSUcg eGhjbWRsYz NRZyBjR2ho Y20xaFkyIF YxZEdsallX d2cgWTI5dG NHRnVhVyBW eklHbHVJSF JvIFpTQjNi M0pzWkMgNG dTR1Z5WlNC aCBjbVVnYz I5dFpTIEJw Ym5SbGNtVn ogZEdsdVp5 Qm1ZVyBOMG N5QmhZbTkx IGRDQjBhR1 VnWTIgOXRj R0Z1ZVRvOC BZbkkrTVM0 Z1NHIGx6ZE c5eWVUb2cg VFdWeVkyc2 dkMiBGeklH OXlhV2RwIG JtRnNiSGtn Wm0gOTFibV JsWkNCcCBi aUF4T0RreE lHIEZ6SUhS b1pTQlYgTG xNdUlITjFZ biBOcFpHbG hjbmtnIGIy WWdkR2hsSU UgZGxjbTFo YmlCTiBaWE pqYXlCbVlX IDFwYkhrZ1 kyOXQgY0dG dWVTd2dkMi BocFkyZ2da R0YwIFpYTW dZbUZqYXkg QjBieUF4Tm pZNCBMaUJV YUdVZ1ZTID VUTGlCaWNt RnUgWTJnZ1 ltVmpZVyAx bElHbHVaR1 Z3IFpXNWta VzUwSUcgUj FjbWx1WnlC WCBiM0pzWk NCWFlYIEln U1M0OFluSS sgTWk0Z1NX NXViMyBaaG RHbHZiam9n IFRXVnlZMn NnYUcgRnpJ R0psWlc0Zy BjbVZ6Y0c5 dWMyIGxpYk dVZ1ptOXkg SUhObGRtVn lZVyB3Z1oz SnZkVzVrIF luSmxZV3Rw Ym0gY2daSE oxWjNNZyBZ VzVrSUhaaF kyIE5wYm1W eklHOTIgWl hJZ2RHaGxJ SCBsbFlYSn pMQ0JwIGJt TnNkV1JwYm 0gY2dkR2hs SUdSbCBkbV ZzYjNCdFpX IDUwSUc5bU lIUm8gWlNC bWFYSnpkQy BCdFpXRnpi R1Z6IElIWm hZMk5wYm0g VWdhVzRnZE dobCBJREU1 TmpCekxDIE IwYUdVZ1NG QlcgSUhaaF kyTnBibSBV Z1IyRnlaR0 Z6IGFXd3NJ R0Z1WkMgQj BhR1VnWTJo diBiR1Z6ZE dWeWIyIHd0 Ykc5M1pYSn AgYm1jZ1pI SjFaeSBCYW IyTnZjaTQ4 IFluSStNeT RnVW0gVnpa V0Z5WTJnZy BSbTlqZFhN NklFIDFsY2 1OcklHbHUg ZG1WemRITW dhRyBWaGRt bHNlU0JwIG JpQnlaWE5s WVggSmphQ0 JoYm1RZyBa R1YyWld4dm NHIDFsYm5R dUlGUm8gWl NCamIyMXdZ VyA1NUlHaG hjeUJoIElH eHZibWN0Yz MgUmhibVJw Ym1jZyBZMj l0YldsMGJX IFZ1ZENCMG J5QmggWkha aGJtTnBibS BjZ2FHVmhi SFJvIFkyRn laU0IwYUgg SnZkV2RvSU hOaiBhV1Z1 WTJVZ1lXID VrSUdoaGN5 QmggSUdScG RtVnljMiBV Z2NHbHdaV3 hwIGJtVWdk R2hoZEMgQn BibU5zZFdS bCBjeUIwY2 1WaGRHIDFs Ym5SeklHWn YgY2lCa2FX RmlaWCBSbG N5d2dZMkZ1 IFkyVnlMQ0 JoYm0gUWdh VzVtWldOMC BhVzkxY3lC a2FYIE5sWV hObGN5NDgg WW5JK05DNG dSMiB4dllt RnNJRkpsIF lXTm9PaUJO WlggSmpheU J2Y0dWeSBZ WFJsY3lCcG JpIEJ0YjNK bElIUm8gWV c0Z01UUXdJ RyBOdmRXNT BjbWxsIGN5 d2diV0ZyYV cgNW5JR2ww Y3lCdyBjbT lrZFdOMGN5 IEJoWTJObG MzTnAgWW14 bElIUnZJRy BFZ2MybG5i bWxtIGFXTm hiblFnY0cg OXlkR2x2Ym lCdiBaaUIw YUdVZ1oyIH h2WW1Gc0lI QnYgY0hWc1 lYUnBiMiA0 dUlFbDBjeU JuIGJHOWlZ V3dnY0ggSm xjMlZ1WTJV ZyBZV3hzYj NkeklHIFp2 Y2lCa2FYWm wgY25ObElH MWhjbSB0bG RITWdZVzVr IElIQmhjbl J1WlggSnph R2x3Y3k0OC BZbkkrTlM0 Z1EyIDl0Yl dsMGJXVnUg ZENCMGJ5Ql RkWCBOMFlX bHVZV0pwIG JHbDBlVG9n VFcgVnlZMn NnYUdGeiBJ RzFoWkdVZ2 MzIFJ5YVdS bGN5QnAgYm lCemRYTjBZ VyBsdVlXSn NaU0J3IGNt RmpkR2xqWl ggTXNJR0Zw YldsdSBaeU IwYnlCeVpX IFIxWTJVZ2 FYUnogSUdW dWRtbHliMi A1dFpXNTBZ V3dnIFptOX ZkSEJ5YVcg NTBJR0Z1Wk NCbSBiMk4x YzJsdVp5IE J2YmlCeVpY TncgYjI1em FXSnNaUyBC emIzVnlZMm x1IFp5d2da VzVsY20gZD VJR1ZtWm1s aiBhV1Z1WT Nrc0lHIEZ1 WkNCM1lYTj AgWlNCeVpX UjFZMyBScG IyNGdhVzRn IGFYUnpJRz FoYm4gVm1Z V04wZFhKcC BibWNnY0hK dlkyIFZ6Yz JWekxqeGkg Y2o0MkxpQk 5aWCBKamF5 Qk5ZVzUxIF lXdzZJRTFs Y20gTnJJSE IxWW14cCBj MmhsY3lCMG FHIFVnVFdW eVkyc2cgVF dGdWRXRnNM QyBCaElIZH BaR1ZzIGVT QnlaWE53Wl cgTjBaV1Fn YldWayBhV0 5oYkNCeVpX IFpsY21WdV kyVWcgWW05 dmF5QjFjMi BWa0lHSjVJ R2hsIFlXeD BhR05oY20g VWdjSEp2Wm 1WeiBjMmx2 Ym1Gc2N5ID RnU1hRZ2FH RnogSUdKbF pXNGdhVyA0 Z2NIVmliR2 xqIFlYUnBi MjRnYzIgbH VZMlVnTVRn NSBPU0JoYm 1RZ2FYIE1n WVhaaGFXeG ggWW14bElH bHVJRyAxMW JIUnBjR3hs IElHeGhibW QxWVcgZGxj eTQ4WW5JKy BOeTRnUTI5 eWNHIDl5WV hSbElGTnYg WTJsaGJDQl NaWCBOd2Iy NXphV0pwIG JHbDBlVG9n VFcgVnlZMn NnYVhNZyBh VzUyYjJ4Ml pXIFFnYVc0 Z2RtRnkgYV c5MWN5Qndh RyBsc1lXNT BhSEp2IGNH bGpJR2x1YV ggUnBZWFJw ZG1WeiBMQ0 JwYm1Oc2RX IFJwYm1jZ1 lXTmogWlhO eklIUnZJRy AxbFpHbGph VzVsIGN5Qm hibVFnYUcg VmhiSFJvWT JGeSBaU0J3 Y205bmNtIE Z0Y3lCcGJp QjEgYm1SbG NuTmxjbiBa bFpDQmpiMj F0IGRXNXBk R2xsY3kgQm hjbTkxYm1R ZyBkR2hsSU hkdmNtIHhr TGlCVWFHVj UgSUdadlkz VnpJRyA5dU lHMWhhMmx1 IFp5Qm9aV0 ZzZEcgaGpZ WEpsSUcxdi BjbVVnWlhG MWFYIFJoWW 14bElHRnUg WkNCaFkyTm xjMyBOcFlt eGxManhpIG NqNDRMaUJC Ym0gbHRZV3 dnU0dWaCBi SFJvT2lCSm JpIEJoWkdS cGRHbHYgYm lCMGJ5Qm9k VyAxaGJpQn dhR0Z5IGJX RmpaWFYwYV cgTmhiSE1z SUUxbCBjbU 5ySUdseklH IEVnYkdWaF pHVnkgSUds dUlIWmxkRy BWeWFXNWhj bmtnIGJXVm thV05wYm0g VXVJRTFsY2 1OciBJRUZ1 YVcxaGJDIE JJWldGc2RH Z2cgYjJabV pYSnpJSCBa aFkyTnBibV Z6IElHRnVa Q0J3YUcgRn liV0ZqWlhW MCBhV05oYk hNZ1ptIDl5 SUd4cGRtVn ogZEc5amF5 QmhibSBRZ1 kyOXRjR0Z1 IGFXOXVJR0 Z1YVcgMWhi SE1zSUdOdi BiblJ5YVdK MWRHIGx1Wn lCemFXZHUg YVdacFkyRn VkRyB4NUlI UnZJSFpsIG RHVnlhVzVo Y24ga2dZMk Z5WlM0OCBZ bkkrT1M0Z1 UzIFJ5YjI1 bklGQnAgY0 dWc2FXNWxP aSBCVWFHVW dZMjl0IGNH RnVlU0JvWV ggTWdZU0J5 YjJKMSBjM1 FnY0dsd1pX IHhwYm1VZ2 IyWWcgWkhK MVozTWdhVy A0Z2RtRnlh VzkxIGN5Qn pkR0ZuWlgg TWdiMllnWk dWMiBaV3h2 Y0cxbGJuIF FzSUdadlkz VnogYVc1bk lHOXVJRyBG eVpXRnpJSE 4xIFkyZ2dZ WE1nYjIgNW piMnh2WjNr cyBJSFpoWT JOcGJtIFVn WkdWMlpXeH YgY0cxbGJu UXNJRyBGdV pDQnBibVps IFkzUnBiM1 Z6SUcgUnBj MlZoYzJWei BMaUJVYUds eklHIE52Ym 5ScGJuVnYg ZFhNZ2FXNX ViMyBaaGRH bHZiaUJ3IG JHRjVjeUJo SUcgTnlkV0 5wWVd3ZyBj bTlzWlNCcG JpIEJwZEhN Z1ozSnYgZD NSb0xqeGlj aiA0eE1DNG dSVzF3IGJH OTVaV1VnUT MgVnNkSFZ5 WlRvZyBUV1 Z5WTJzZ2FY IE1nYTI1dm QyNGcgWm05 eUlHbDBjeS BCamIyMXRh WFJ0IFpXNT BJSFJ2SUgg ZHZjbXR3Yk dGaiBaU0Jr YVhabGNuIE 5wZEhrZ1lX NWsgSUdWdG NHeHZlVyBW bElIZGxiR3 d0IFltVnBi bWN1SUYgUm 9aU0JqYjIx dyBZVzU1SU dWdGNHIGho YzJsNlpYTW cgWVNCamRX eDBkWCBKbE lHOW1JR2x1 IFkyeDFjMm x2YmkgQmhi bVFnYzNWdy BjRzl5ZEN3 Z2MzIFJ5YV hacGJtY2cg ZEc4Z1kzSm xZWCBSbElH RnVJR1Z1IG RtbHliMjV0 WlcgNTBJSG RvWlhKbCBJ R1Z0Y0d4dm VXIFZsY3lC allXNGcgZE doeWFYWmxM aiB4aWNqNV VhR1Z6IFpT QmhjM0JsWT MgUnpJR2hw WjJocyBhV2 RvZENCTlpY IEpqYStLQW 1YTWcgYzJs bmJtbG1hVy BOaGJuUWdh VzF3IFlXTj BJRzl1SUcg aGxZV3gwYU dOaCBjbVVz SUhKbGMyIF ZoY21Ob0xD QmggYm1RZ1 kyOXljRyA5 eVlYUmxJSE psIGMzQnZi bk5wWW0gbH NhWFI1TGp4 aSBjajQ9Ci AgICAgICAg PC9zcGFuPg ogICAgICAg IAogICAgIC AgIA==
See Company Q&A
π Get full analytics about Merck
Sign up for free
or
log in
β‘ Instantly access "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!